Results 171 to 180 of about 98,415 (200)

Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease

Endocrine Reviews, 2023
Daniel J Drucker
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh
exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly  

Glucagon Like Peptide 1 Receptor

2018
openaire   +2 more sources

Negative allosteric modulation of the glucagon receptor by RAMP2

Cell, 2023
Brian K Kobilka
exaly  

Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor

British Journal of Pharmacology, 2022
Thomas Munzel, Andreas Daiber, Sebastian Steven   +2 more
exaly  

Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis

Lancet, The, 2014
Caroline K Kramer, Bernard Zinman Cm, Ravi Retnakaran   +2 more
exaly  

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

Nature Medicine, 2003
Matthew J During, Helen L Fitzsimons, Matthias Klugmann   +2 more
exaly  

[Glucagon-like peptide-1 receptor agonists].

Nihon rinsho. Japanese journal of clinical medicine, 2012
Takeshi, Kurose, Yutaka, Seino
openaire   +1 more source

Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

Circulation, 2008
Kiwon Ban, Mansoor Husain
exaly